Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 5941-5950 Newer>

Fast Company November 2009 David H. Freedman	The Gene Bubble: Why We Still Aren't Disease-Free When the human genome was first sequenced nearly a decade ago, the world lit up with talk about how new gene-specific drugs would help us cheat death. Well, the verdict is in: Keep eating those greens.
Fast Company November 2009 Stephanie Schomer	Lost Dollars in Gene Research Billions of R&D dollars flowed to companies promising to cure our ills. Most of those companies are now dead or forgotten.
The Motley Fool October 14, 2009 Brian Orelli	Consistency Makes This Stock a Winner Abbott turns in a solid quarter, but it needs to keep branching out.
The Motley Fool October 13, 2009 Brian Orelli	J&J Needs to Get Drugged Up Medical devices and diagnostics pass by drugs as the main revenue source.
The Motley Fool October 13, 2009 Brian Orelli	Health-Care Reform: You Can't Have It Both Ways Requiring insurers to cover pre-existing conditions needs to go hand-in-hand with requiring healthy people to purchase insurance.
The Motley Fool October 13, 2009 Dave Mock	A Big Upgrade for Teva Pharmaceutical This bullish call comes from more than just one analyst.
CIO October 12, 2009 Kristin Burnham	How Le Bonheur Children's Medical Center Rebuilt its Facility Engaging stakeholders in a board game helped prioritize high-tech amenities.
The Motley Fool October 12, 2009 Brian Orelli	Onyx Strikes Gold A nice pipeline pickup for this pharmaceutical company.
The Motley Fool October 12, 2009 Robert Steyer	Healthy Spinoffs, Happy Investors When medical companies spin off unwanted divisions, the spinoffs can outperform the parent.
The Motley Fool October 7, 2009 Dave Mock	A Big Upgrade for Tenet Healthcare This bullish call comes from more than just one analyst.
<Older 5941-5950 Newer> Return to current articles.